Motorola Solutions MSI - Chaîne d'options | ADVFN

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Motorola Solutions Inc (MSI)

438,14

-27,91

(-5,99%)

Fermé 15 Février 10:00PM

Retardé de 15 minutes

438,14

0,00

( 0,00% )

Avant marché: 1:28PM

Retardé de 15 minutes

MSI Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
340,00	128,94	128,94	128,94	128,94	0,00	0,00 %	0	1	-
350,00	86,60	89,60	125,30	88,10	0,00	0,00 %	0	12	-
360,00	76,00	80,50	0,00	78,25	0,00	0,00 %	0	0	-
370,00	45,20	45,20	45,20	45,20	0,00	0,00 %	0	0	-
380,00	56,60	60,40	77,70	58,50	0,00	0,00 %	0	2	-
390,00	46,70	49,70	81,55	48,20	0,00	0,00 %	0	5	-
400,00	36,80	39,60	69,33	38,20	0,00	0,00 %	0	15	-
410,00	62,05	62,05	62,05	62,05	0,00	0,00 %	0	13	-
420,00	17,60	20,50	28,10	19,05	-18,80	-40,09 %	1	36	14/2/2025
430,00	8,90	11,30	12,40	10,10	-24,25	-66,17 %	6	9	14/2/2025
440,00	2,95	5,30	5,40	4,125	-23,95	-81,60 %	3	26	14/2/2025
450,00	1,50	1,50	1,50	1,50	0,00	0,00 %	0	49	-
460,00	0,10	0,80	0,65	0,45	-13,65	-95,45 %	35	47	14/2/2025
470,00	0,20	0,40	0,15	0,30	-9,25	-98,40 %	35	177	14/2/2025
480,00	0,10	0,50	0,06	0,30	-6,07	-99,02 %	27	450	14/2/2025
490,00	0,10	0,10	0,10	0,10	0,00	0,00 %	0	155	-
500,00	0,10	0,10	0,10	0,10	-2,20	-95,65 %	63	749	14/2/2025
510,00	0,10	0,10	0,10	0,10	0,00	0,00 %	0	52	-
520,00	0,10	0,10	0,10	0,10	0,00	0,00 %	0	53	-
530,00	0,54	0,54	0,54	0,54	0,00	0,00 %	0	55	-

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
340,00	1,50	1,50	1,50	1,50	0,00	0,00 %	0	8	-
350,00	0,15	1,35	0,15	0,75	0,00	0,00 %	0	4	-
360,00	0,00	0,00	0,00	0,00	0,00	0,00 %	0	0	-
370,00	0,45	0,45	0,45	0,45	0,00	0,00 %	0	7	-
380,00	0,30	0,30	0,30	0,30	0,00	0,00 %	0	5	-
390,00	0,05	0,65	0,30	0,35	0,00	0,00 %	0	83	-
400,00	0,05	0,30	0,17	0,175	-0,13	-43,33 %	7	180	14/2/2025
410,00	0,31	0,31	0,31	0,31	0,00	0,00 %	0	42	-
420,00	0,35	0,70	0,60	0,525	-0,25	-29,41 %	22	68	14/2/2025
430,00	1,65	1,65	1,65	1,65	0,00	0,00 %	0	51	-
440,00	5,21	5,21	5,21	5,21	0,00	0,00 %	0	79	-
450,00	12,10	15,00	12,95	13,55	7,72	147,61 %	64	131	14/2/2025
460,00	22,00	22,00	22,00	22,00	0,00	0,00 %	0	71	-
470,00	26,80	26,80	26,80	26,80	0,00	0,00 %	0	72	-
480,00	41,72	41,72	41,72	41,72	0,00	0,00 %	0	18	-
490,00	49,90	53,70	51,54	51,80	35,54	222,12 %	42	57	14/2/2025
500,00	61,45	61,45	61,45	61,45	0,00	0,00 %	0	49	-
510,00	70,80	73,80	0,00	72,30	0,00	0,00 %	0	0	-
520,00	79,80	83,80	0,00	81,80	0,00	0,00 %	0	0	-
530,00	89,80	93,90	0,00	91,85	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SLDBSolid Biosciences Inc	US$ 7,02 (74,19%)	17,06M
EFOIEnergy Focus Inc	US$ 2,15 (66,67%)	15,92M
INTGIntergroup Corporation	US$ 22,80 (61,13%)	6
EDRYEuroDry Ltd	US$ 16,69 (58,95%)	8
FGMCFG Merger II Corporation	US$ 14,85 (54,45%)	11
RSLSReShape Lifesciences Inc	US$ 0,99 (-57,51%)	1,29M
INNVInnovAge Holding Corporation	US$ 1,81 (-46,61%)	1
KTCCKeyTronic Corporation	US$ 2,01 (-36,79%)	1
DAREDare Bioscience Inc	US$ 2,01 (-33,88%)	3
BPTHBio Path Holdings Inc	US$ 0,4199 (-33,69%)	595,09k
ADTXAditxt Inc	US$ 0,0826 (18,00%)	160,77M
GLYCGlycoMimetics Inc	US$ 0,3679 (26,86%)	26,82M
HCTIHealthcare Triangle Inc	US$ 0,7388 (54,27%)	21,67M
DGLYDigital Ally Inc	US$ 0,0812 (5,87%)	20,43M
SLDBSolid Biosciences Inc	US$ 7,02 (74,19%)	17,06M

i_like_bb_stock

i_like_bb_stock il y a 5 minutes

ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

i_like_bb_stock

i_like_bb_stock il y a 5 minutes

Juntao

Juntao il y a 5 minutes

i_like_bb_stock

i_like_bb_stock il y a 6 minutes

news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

i_like_bb_stock

i_like_bb_stock il y a 6 minutes

ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

IhidfromtheX

IhidfromtheX il y a 6 minutes

Ok...Talk of the FDA slowing down etc...No problem here... https://finance.yahoo.com/news/chimerix-announces-fda-acceptance-priority-120000372.html

Sideem

Sideem il y a 7 minutes

Good to see the pre-green. Will the green stay?

georgie18

georgie18 il y a 7 minutes

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

georgie18

georgie18 il y a 7 minutes

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

Here Today

Here Today il y a 7 minutes

Huge Believer and buyer of shares of more than 9.99% of all Outstanding Shares

https://www.sec.gov/Archives/edgar/data/1829635/000095017025021455/xslSCHEDULE_13G_X01/primar

georgie18

georgie18 il y a 7 minutes

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

Crawfors

Crawfors il y a 7 minutes

46.5% margins are pretty dang impressive. Can't be upset about that.

$EDXC

georgie18

georgie18 il y a 7 minutes

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

TheFinalCD

TheFinalCD il y a 7 minutes

https://x.com/NuntioBot/status/1891835713668161922

Crawfors

Crawfors il y a 8 minutes

• Revenue increased 164% year-over-year, reaching $632K in Q4 2024, demonstrating growing demand for our products.

• Our gross margin improved to 46.5%, indicating enhanced financial efficiency.

$EDXC

Crawfors

Crawfors il y a 8 minutes

Acknowledging the Challenges
It’s no secret that our financial position has been strained, with limited working capital and a heavy reliance on convertible financing in the past. We’ve experienced dilution, debt pressure, and cash flow constraints, all of which have made it difficult to opera

Torez

Torez il y a 8 minutes

Lots of comedians in here. Short bus party not a yaht party for you all

Crawfors

Crawfors il y a 8 minutes

https://www.newmediawire.com/news/endexx-corporation-announces-filing-of-q4-2024-financials-removal-of-yield-sign-and-ceo-update-on-growth-strategy-7079432?fbclid=IwY2xjawIhZiJleHRuA2FlbQIxMAABHbyr1bnNTeqMN7dIxtbLtKWPJT_Z-BarsdskOUFhhbk4Yv8wmDhd56UjXg_aem_MXr--hJ2dCo1HspBvETtkA

newmedman

newmedman il y a 9 minutes

Bombs are going to fly. If you thought trump was a dumbfuck just wait for what's coming.

RobotDroid

RobotDroid il y a 9 minutes

A no name reasearch group spews fiction for the paid pumpers. Wow, not impressive at all. Hopium rules, reality falls!

AyaStocks

AyaStocks il y a 9 minutes

GM $ADIA players! Watching for a move back up to higher levels today. This is way undervalued here below a dime.

Crawfors

Crawfors il y a 10 minutes

Here Today

Here Today il y a 10 minutes

Watch Out FDA!!!! There is a new Sheriff in town and all your CROOKED DEALS with those Big Pharma's of the world trying to STOP and Destroy new Treatments and or cures before they can begin is coming to an end in my opinion!!!!

fredscott36

fredscott36 il y a 11 minutes

25/marty to venable.

...

georgie18

georgie18 il y a 11 minutes

SEPN...$13.70...🥳...T3 Halt...

georgie18

Member Level
Re: georgie18 post# 674144

Friday, February 14, 2025 3:31:11 PM

Post#
674545
of 674615
SEPN...$13.03...🥳...Slowly creeping up...

Motorola Solutions

Vontobel Financial Produ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales